All NeurAxis Products

  • U.S. Patent No. 7,252,319

  • U.S. Patent No. 9,662,269
  • U.S. Patent No. 9,839,577
  • U.S. Patent No. 10,010,479
  • U.S. Patent No. 10,322,062
  • U.S. Patent No. 10,413,719
  • U.S. Patent No. 10,792,500

  • U.S. Patent No. 11,077,019

  • U.S. Patent No. 12,433,540 (RED Device)

  • U.S. Patent No. 11,331,473
  • U.S. Patent No. 11,369,791
  • U.S. Patent No. 11,654,082
  • U.S. Patent No. 11,684,782

  • U.S. Patent No. 11,813,448
  • U.S. Patent No. 12,029,701

  • U.S. Patent No. 12,097,371

  • U.S. Patent No. 12,285,602

Additional patents pending.

Neuromodulation Therapies for Chronic and Debilitating Conditions

Neuromodulation Therapies for Chronic and Debilitating Conditions

Targeted therapies for patients suffering from disorders of the gut-brain interaction (DGBI): functional abdominal pain associated with irritable bowel syndrome, functional dyspepsia (FD), and FD-related nausea symptoms.